Skip to content
Thursday 27 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,792.54
-0.79%
DAX
26,367.24
+0.31%
CAC 40
8,319.87
-1.68%
STOXX 50
6,424.73
-0.71%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 27 August 2024 8:05 am

Flowtech buys out struggling rival Thorite to boost UK expansion

By: Bethany Wales

Add as a preferred source on Google
Flowtech will acquire Thorite's equipment, vehicles, stock, and other assets.
Flowtech will acquire Thorite's equipment, vehicles, stock, and other assets.

Fluid power products supplier, Flowtech, has struck a £350,000 deal to acquire the struggling pneumatics and fluid products provider Thorite.

The London-listed firm, which is headquartered in Flookburgh, Cumbria, said the acquisition would bring “significant benefits” including better operational efficiency, cost savings, and improved profit margins.

It added that Thorite’s existing locations would help Flowtech expand into new areas across the UK, offering additional products and services with “minimal overlap”.

The combined business is also expected to see strong opportunities for cross-selling products to each company’s customer base, enhancing overall growth.

Flowtech will acquire Thorite’s equipment, vehicles, stock, and other assets. Additionally, Flowtech had paid off Thorite’s £1.7m debt in exchange for a debtor book valued at £2.6m.

This transaction also includes a deal to share any extra funds recovered from the debtor book.

Despite Thorite’s recent financial struggles, including an estimated £1.2m loss for the year ending in March 2024, Flowtech said it expected to restore profitability within the first year of ownership.

Read more

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

In the year ended 31 March 2023, Thorite generated revenue of £21.2m and delivered an operating profit of £79,000. 

Mike England, CEO of Flowtech, said: “We are delighted to acquire this well-respected brand and skilled workforce. On behalf of all of us at Flowtech we welcome our new colleagues to the group.

“This is an exciting moment for us all as both businesses have a history of deep expertise and knowledge in power, motion and control.

“For us at Flowtech, adding Thorite’s expertise in pneumatics, automation and compressed air capability is an excellent fit and aligns perfectly with our strategy – a world of motion – which will enhance our scale, margin profile, and help to accelerate market share gains.”

Flowtech said that following the acquisition, it would delay the release of its half-year results for the period ending 30 June 2024 in order to allow management to focus on integrating the new business and provide shareholders with more information about the acquisition’s benefits.

It added that the new date would be announced by 30 September 2024.

Read more

Cut student loan repayments to get youths out of chicken shops 

Three young adults enjoying chicken burgers and drinks from a food truck, casually dining outdoors.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

People & Organisations

  • Flowtech
  • London Stock Exchange
  • Thorite

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Andy Burnham hints at tax rises in Autumn Budget

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

More from Morning Wire

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Cut student loan repayments to get youths out of chicken shops 

    Retail
    Three young adults enjoying chicken burgers and drinks from a food truck, casually dining outdoors.
  • Could a ‘land blocking’ rule change spell danger for Aldi and Lidl?

    Retail
    Lidl supermarket sign with blue, yellow, and red logo against a clear blue sky
  • Cliganic Launches at Planet Organic, Bringing Consumers Back to the Roots of Organic Beauty in the UK

    Business Wire
  • e.l.f. and Bubble Launch Limited-Edition Hybrid Holy Grails in Skincare-Makeup Collaboration

    Business Wire
  • Burnham takes on ‘rip-off’ discounts and subscriptions in cost of living push

    Politics
    Andy Burnham, Mayor of Greater Manchester, in a suit and glasses, looking serious against a bright sky.
  • Fanplayr Launches Catalog Intelligence, Transforming Product Catalogs into AI-Ready Product Intelligence

    Business Wire
  • Amazon says it buys books in bulk to ‘improve products’

    Tech
    Bloomsbury was voted Publisher of the Year at the British Book Awards 2025.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook